Bitcoin is trading around $63,038, about 19% below its May peak near $77,500, prompting some skepticism about its future value. Citi, Standard Chartered, and TD Cowen have all lowered their 2026 Bitcoin price targets, reflecting softer demand and regulatory uncertainties. Meanwhile, gold prices have surged past $4,400 an ounce, supported by a 62% increase in central bank purchases, highlighting gold's continued strength as a defensive asset. This contrast underscores ongoing debates about Bitcoin's role as a hedge versus traditional safe havens like gold.
Anteris Technologies received regulatory approval from Germany's BfArM to start enrolling patients in its global PARADIGM trial for the DurAVR Transcatheter Heart Valve. This approval allows the company to recruit patients at leading German centers, ...
XBiotech announced positive final efficacy results from its phase II TASKIN trial for vilamakitug (XB2001) in refractory metastatic colorectal cancer. The study, funded by the French National Cancer Institute, showed a 61.3% overall survival rate at ...
XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...
Hyperliquid (HYPE) has surpassed Bitcoin (BTC) and Ether (ETH) in a 30-day analyst sentiment index, indicating a more positive outlook from market analysts over the past month. The index, which updates hourly and counts one vote per analyst, measures...
Grupo Aeroportuario del Pacífico reported a 21.8% increase in total revenues for Q3 2026, driven by higher aeronautical and non-aeronautical services and the integration of Cross Border Xpress (CBX). Net income rose 8.1% to Ps. 2.91 billion despite a...
